Perspectives
Perspectives: Dr. Jerry Mendell discusses Duchenne muscular dystrophy and gene therapy
Feb. 15, 2022
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Varying degrees of atrophy illustrate the impact of PCH2 on the cerebral cortex. Left: T1-weighted lateral sagittal image of cerebral cortex in an 11-month-old female patient with minimal signs of atrophy. Right: Lateral sagittal T1-weighted image of 15-year-old boy with advanced cerebral cortical atrophy. (Contributed by Dr. Peter Barth.)